2,118
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a cross-sectional conjoint experiment in Spain and Italy

, , , , , , , , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 1080-1091 | Received 28 Aug 2018, Accepted 08 Jan 2019, Published online: 15 Apr 2019

References

  • Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von König CH. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J. 2015;34(9):e222–e232. doi:10.1097/INF.0000000000000795.
  • Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi AE, Zanetti A, Zuccotti G. Pertussis. Hum Vaccin Immunother. 2015;11(1):108–17. doi:10.4161/hv.34364.
  • Suryadevara M, Domachowske JB. Prevention of pertussis through adult vaccination. Hum Vaccin Immunother. 2015;11(7):1744–47. doi:10.1080/21645515.2015.1038442.
  • Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013;13:151. doi:10.1186/1471-2334-13-151.
  • Plans-Rubió P, Navas E, Godoy P, Carmona G, Domínguez A, Jané M, Muñoz-Almagro C, Brotons P. Reduction of direct health costs associated with pertussis vaccination with acellular vaccines in children aged 0–9 years with pertussis in Catalonia (Spain). Pharmacoecon Open. 2018. [Epub ahead of print]. doi:10.1007/s41669-018-0081-4.
  • Oliveira SM, Gonçalves-Pinho M, Freitas A, Guimarães H, Azevedo I. Trends and costs of pertussis hospitalizations in Portugal, 2000 to 2015: from 0 to 95 years old. Infect Dis (Lond). 2018;50(8):625–33. doi:10.1080/23744235.2018.1457796.
  • Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, Greiner W. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016;61(7):847–60. doi:10.1007/s00038-016-0842-8.
  • Forsyth K, Plotkin S, Tan T, Wirsing von König CH. Strategies to decrease pertussis transmission to infants. Pediatrics. 2015;135(6):e1475–e1482. doi:10.1542/peds.2014-3925.
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1424–26.
  • de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50(10):1339–45. doi:10.1086/652281.
  • de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology. 2012;23(6):852–60. doi:10.1097/EDE.0b013e31826c2b9e.
  • Blain AE, Lewis M, Banerjee E, Kudish K, Liko J, McGuire S, Selvage D, Watt J, Martin SW, Skoff TH. An assessment of the cocooning strategy for preventing infant pertussis-United States, 2011. Clin Infect Dis. 2016;63(suppl 4):S221–S226. doi:10.1093/cid/ciw528.
  • Cohen R, Gaudelus J, Denis F, Stahl JP, Chevaillier O, Pujol P, Martinot A. Pertussis vaccination coverage among French parents of infants after 10years of cocoon strategy. Med Mal Infect. 2016;46(4):188–93. doi:10.1016/j.medmal.2016.03.005.
  • Lempereur de Guerny MC, Scauflaire M, Crabot D, Le Cossec C, Partouche H. [Pertussis immunization within three adult populations concerned by cocoon strategy in Île-de-France]. Rev Epidemiol Sante Publique. 2017;65(6):389–95. doi:10.1016/j.respe.2017.06.007.
  • Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infect Dis. 2014;14:397. doi:10.1186/1471-2334-14-397.
  • Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill. 2010;15(16): pii=19548.
  • Rowe SL, Cunningham HM, Franklin LJ, Lester RA. Uptake of a government-funded pertussis-containing booster vaccination program for parents of new babies in Victoria, Australia. Vaccine. 2015;33(15):1791–96. doi:10.1016/j.vaccine.2015.02.051.
  • Wong CY, Thomas NJ, Clarke M, Boros C, Tuckerman J, Marshall HS. Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations. Hum Vaccin Immunother. 2015;11(5):1165–72. doi:10.1080/21645515.2015.1019188.
  • Hayles EH, Cooper SC, Wood N, Sinn J, Skinner SR. What predicts postpartum pertussis booster vaccination? A controlled intervention trial. Vaccine. 2015;33(1):228–36. doi:10.1016/j.vaccine.2014.10.074.
  • Donnan EJ, Fielding JE, Rowe SL, Franklin LJ, Vally H. A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia. BMC Public Health. 2013;13:676. doi:10.1186/1471-2458-13-676.
  • Visser O, Kraan J, Akkermans R, Ruiter RAC, van der Velden K, Hautvast JLA, Hulscher MEJL. Assessing determinants of the intention to accept a pertussis cocooning vaccination: a survey among Dutch parents. Vaccine. 2016;34(39):4744–51. doi:10.1016/j.vaccine.2016.07.024.
  • Visser O, Hautvast JL, van der Velden K, Hulscher ME. Intention to accept pertussis vaccination for cocooning: a qualitative study of the determinants. PLoS One. 2016;11(6):e0155861. doi:10.1371/journal.pone.0155861.
  • Visser O, Hulscher MEJL, Antonise-Kamp L, Akkermans R, van der Velden K, Ruiter RAC, Hautvast JLA. Assessing determinants of the intention to accept a pertussis cocooning vaccination: a survey among healthcare workers in maternity and paediatric care. Vaccine. 2018;36(5):736–43. doi:10.1016/j.vaccine.2017.12.021.
  • Centro Nacional de Epidemiología. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiológica de España. Situación de la tos ferina en España, 1998–2016. Análisis preliminar del impacto de la vacunación de tos ferina en embarazadas. Madrid (Spain): Ministerio de Economía y Empresa; 2018 Apr 25 [accessed 2018 Jul 12]. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-enfermedades-prevenibles-vacunacion/pdf_2018/Situacion_de_la_Tos_ferina_en_Espana_1998-2016.pdf.
  • Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romo F, Moraga-Llop FA, Arístegui-Fernández J, Goncé-Mellgren A, Bayas JM, Salleras-Sanmartí L. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis working group]. Enferm Infecc Microbiol Clin. 2013;31(4):240–53. doi:10.1016/j.eimc.2012.12.011.
  • Simonetti A, Martini I, Bonomo G, D’Avino R, Puggina P, Vairo U, Piscopo P, Marchetti F. Improving adherence rates to a cocooning program: a pilot experience in Italy. Hum Vaccin Immunother. 2013;9(5):1142–45. doi:10.4161/hv.23795.
  • Tozzi AE, Rosati GV, Ciarrocchi G, Ferrera G, Gabutti G, Giuffrida S, Locuratolo F, Marchetti F, Mereu G, Pellegrino A, et al. Riduzione del rischio di pertosse nel neonato mediante vaccinazione: la strategia cocoon in Italia. Riv Immunol Allergol Pediatr. 2012;2(suppl 3):1–14.
  • de Bekker-Grob EW, Hofman R, Donkers B, van Ballegooijen M, Helmerhorst TJ, Raat H, Korfage IJ. Girls’ preferences for HPV vaccination: a discrete choice experiment. Vaccine. 2010;28(41):6692–97. doi:10.1016/j.vaccine.2010.08.001.
  • Hofman R, de Bekker-Grob EW, Richardus JH, de Koning HJ, van Ballegooijen M, Korfage IJ. Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment. PLoS One. 2014;9(8):e104772. doi:10.1371/journal.pone.0104772.
  • Michaels-Igbokwe C, MacDonald S, Currie GR. Individual preferences for child and adolescent vaccine attributes: a systematic review of the stated preference literature. Patient. 2017;10(6):687–700. doi:10.1007/s40271-017-0244-x.
  • Seanehia J, Treibich C, Holmberg C, Müller-Nordhorn J, Casin V, Raude J, Mueller JE. Quantifying population preferences around vaccination against severe but rare diseases: a conjoint analysis among French university students, 2016. Vaccine. 2017;35(20):2676–84. doi:10.1016/j.vaccine.2017.03.086.
  • Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers’ preferences for travel vaccines assessed by a discrete choice experiment. Vaccine. 2018;36(7):969–78. doi:10.1016/j.vaccine.2018.01.004.
  • Cunningham CE, Deal K, Chen Y. Adaptive choice-based conjoint analysis: a new patient-centered approach to the assessment of health service preferences. Patient. 2010;3(4):257–73. doi:10.2165/11537870-000000000-00000.
  • de Groot IB, Otten W, Smeets HJ, Marang-van de Mheen PJ; CHOICE-2 study group. Is the impact of hospital performance data greater in patients who have compared hospitals? BMC Health Serv Res. 2011;11:214. doi:10.1186/1472-6963-11-214.
  • Whitman CB, Shreay S, Gitlin M, van Oijen MG, Spiegel BM. Clinical factors and the decision to transfuse chronic dialysis patients. Clin J Am Soc Nephrol. 2013;8(11):1942–51. doi:10.2215/CJN.00160113.
  • Al-Omari B, Sim J, Croft P, Frisher M. Generating individual patient preferences for the treatment of osteoarthritis using adaptive choice-based conjoint (ACBC) analysis. Rheumatol Ther. 2017;4(1):167–82. doi:10.1007/s40744-017-0056-4.
  • Chapman CN, Alford JL, Johnson C, Weidemann R, Lahav M. CBC vs. ACBC: comparing results with real product selection. Research Paper Series. Sequim (WA): Sawtooth Software, Inc; 2009 [accessed 2018 Apr 10]. https://www.sawtoothsoftware.com/support/technical-papers/adaptive-cbc-papers/cbc-vs-acbc-comparing-results-with-real-product-selection-2009.
  • Jervis SM, Ennis JM, Drake MA. A comparison of adaptive choice‐based conjoint and choice‐based conjoint to determine key choice attributes of sour cream with limited sample size. J Sens Stud. 2009;27(6):451–62. doi:10.1111/joss.12009.
  • Bauer R, Menrad K, Decker T. Adaptive hybrid methods for choice-based conjoint analysis: a comparative study. Int J Mark Stud. 2015;7(1):1–14. doi:10.5539/ijms.v7n1p1.
  • Liu Q, Otter T, Allenby GM. Investigating endogeneity bias in marketing. Market Sci. 2007;26(5):642–50. doi:10.1287/mksc.1060.0256.
  • Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013;31(4):618–25. doi:10.1016/j.vaccine.2012.11.052.
  • O’Leary ST, Pyrzanowski J, Brewer SE, Barnard J, Beaty B, Donnelly M, Mazzoni S, Dempsey AF. Influenza and pertussis vaccination among pregnant women and their infants’ close contacts: reported practices and attitudes. Pediatr Infect Dis J. 2015;34(11):1244–49. doi:10.1097/INF.0000000000000873.
  • Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J. Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine. 2013;31(37):3972–78. doi:10.1016/j.vaccine.2013.06.015.
  • Zhou M, Zhao L, Kong N, Campy KS, Wang S, Qu S. Predicting behavioral intentions to children vaccination among Chinese parents: an extended TPB model. Hum Vaccin Immunother. 2018;1–7. [Epub ahead of print]. doi:10.1080/21645515.2018.1496765.
  • Ndwandwe D, Uthman OA, Adamu AA, Sambala EZ, Wiyeh AB, Olukade T, Bishwajit G, Yaya S, Okwo-Bele JM, Wiysonge CS. Decomposing the gap in missed opportunities for vaccination between poor and non-poor in sub-Saharan Africa: a multicountry analyses. Hum Vaccin Immunother. 2018;14(10):2358–64. doi:10.1080/21645515.2018.1467685.
  • Suryadevara M, Bonville CA, Cibula DA, Valente M, Handel A, Domachowse JR, Domachowske JB. Pertussis vaccine for adults: knowledge, attitudes, and vaccine receipt among adults with children in the household. Vaccine. 2014;32(51):7000–04. doi:10.1016/j.vaccine.2014.10.018.
  • Fernández-Cano MI, Armadans Gil L, Campins Martí M. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies. Vaccine. 2015;33(19):2213–20. doi:10.1016/j.vaccine.2015.03.045.
  • Krueger RA, Casey MA. Focus groups: a practical guide for applied research. Thousand Oaks (CA): SAGE Publications, Inc.; 2009.
  • de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–84. doi:10.1007/s40271-015-0118-z.
  • Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge (United Kingdom): Cambridge University Press; 2000.